“Tofacitinib counteracts IL-6 overexpression induced by deficient autophagy: implications in Sjögren’s syndrome”. Rheumatology. (2020) 1–12. DOI: 10.1093/rheumatology/keaa670.


Authors

Barrera MJ, Aguilera S, Castro I, Matus S, Carvajal P, Molina C, González S, Jara D, Hermoso M, and María Julieta González.

Lab(s)


Comparte: